| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 10 |
| 1 | DALFAMPRIDINE | 7 |
| 2 | BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE | 5 |
| 3 | CABOTEGRAVIR | 4 |
| 4 | CABOTEGRAVIR AND RILPIVIRINE | 4 |
| 5 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 4 |
| 6 | FINGOLIMOD HCL | 4 |
| 7 | RILPIVIRINE | 4 |
| 8 | RITUXIMAB | 4 |
| 9 | RIBAVIRIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE | 1 | 0.0013 |
| 1 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 4 | 0.0011 |
| 2 | CABOTEGRAVIR AND RILPIVIRINE | 4 | 0.0006 |
| 3 | RILPIVIRINE | 4 | 0.0006 |
| 4 | ALEMTUZUMAB | 10 | 0.0005 |
| 5 | CABOTEGRAVIR | 4 | 0.0005 |
| 6 | ETRAVIRINE | 1 | 0.0002 |
| 7 | BENDAMUSTINE HCL | 2 | 0.0001 |
| 8 | DOXYCLYCLINE HYCLATE | 2 | 0.0001 |
| 9 | OXYBUTYNIN CHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 10 | 0.0005 |
| 1 | Potassium Channel Blocker [EPC] | 7 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Analog Antiviral [EPC] | 3 | 0.0000 |
| 7 | Tetracycline-class Drug [EPC] | 2 | 0.0000 |
| 8 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |